(Q53542970)

15 May 2018

title

[Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor] (English)

1 reference

15 May 2018

Fluorodeoxyglucose Positron Emission Tomography

main subject

1 reference

Fakhry N

1

1 reference

15 May 2018

Jacob T

2

1 reference

15 May 2018

Paris J

3

1 reference

15 May 2018

Barberet M

4

1 reference

15 May 2018

Mundler O

5

1 reference

15 May 2018

Giovanni A

6

1 reference

15 May 2018

Zanaret M

7

1 reference

15 May 2018

publication date

1 February 2006

1 reference

15 May 2018

Annales d'Oto-Laryngologie et de Chirurgie Cervico-Faciale

published in

1 reference

15 May 2018

volume

123

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

17-25

1 reference

15 May 2018

Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Unknown primary squamous cell carcinoma metastatic to the neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Cervical nodal metastases of unknown origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Diagnosis and management of carcinoma of unknown primary in the head and neck.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Diagnostic strategies in cervical carcinoma of an unknown primary (CUP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Cancer of unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Can positron emission tomography improve the quality of care for head-and-neck cancer patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

PET scanning in head and neck oncology: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Uses and limitations of FDG positron emission tomography in patients with head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Positron emission tomography in the early follow-up of advanced head and neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Positron emission tomography in the management of unknown primary head and neck carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

The impact of FDG PET on the management of occult primary head and neck tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Unknown primary tumors: detection with dual-modality PET/CT--initial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

Normal FDG distribution patterns in the head and neck: PET/CT evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-438X%2806%2976634-8

10.1016/S0003-438X(06)76634-8

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018